RT Journal Article
SR Electronic
T1 Pre-trained Multimodal Large Language Model Enhances Dermatological Diagnosis using SkinGPT-4
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.06.10.23291127
DO 10.1101/2023.06.10.23291127
A1 Zhou, Juexiao
A1 He, Xiaonan
A1 Sun, Liyuan
A1 Xu, Jiannan
A1 Chen, Xiuying
A1 Chu, Yuetan
A1 Zhou, Longxi
A1 Liao, Xingyu
A1 Zhang, Bin
A1 Gao, Xin
YR 2023
UL http://medrxiv.org/content/early/2023/09/06/2023.06.10.23291127.abstract
AB Large language models (LLMs) are seen to have tremendous potential in advancing medical diagnosis recently. However, it is important to note that most current LLMs are limited to text interaction alone. Meanwhile, the development of multimodal large language models for medical diagnosis is still in its early stages, particularly considering the prevalence of image-based data in the field of medical diagnosis, among which dermatological diagnosis is a very important task as skin and subcutaneous diseases rank high among the leading contributors to the global burden of nonfatal diseases. Inspired by current state-of-the-art multimodal large language models, we present SkinGPT-4, which is the world’s first interactive dermatology diagnostic system based on multimodal large language models. To implement SkinGPT-4, we have designed a new framework that aligned a pre-trained vision transformer with a large language model named Falcon-40B-Instruct, which is based on Falcon. To train SkinGPT-4, we have collected an extensive collection of skin disease images (comprising 52,929 publicly available and proprietary images) along with clinical concepts and doctors’ notes and designed a two-step training strategy. To demonstrate the robustness of SkinGPT-4, we have conducted quantitative evaluations on 150 real-life cases, which were independently reviewed by certified dermatologists. With SkinGPT-4, users could upload their own skin photos for diagnosis, and the system could autonomously evaluate the images, identifies the characteristics and categories of the skin conditions, performs in-depth analysis, and provides interactive treatment recommendations. Meanwhile, SkinGPT-4’s local deployment capability and commitment to user privacy also render it an appealing choice for patients. Though SkinGPT-4 is not a substitute for doctors, it could enhance users’ comprehension of their medical conditions, facilitate improve communication between patients and doctors, expedite the diagnostic process for dermatologists, facilitate triage, and potentially promote human-centred care and healthcare equity in underdeveloped areas. In summary, SkinGPT-4 represents a significant leap forward in the field of dermatology diagnosis in the era of large language models and a valuable exploration of multimodal large language models in medical diagnosis.Competing Interest StatementThe authors have declared no competing interest.Funding StatementJuexiao Zhou, Xiuying Chen, Yuetan Chu, Longxi Zhou, Xingyu Liao, Bin Zhang, and Xin Gao were supported in part by grants from the Office of Research Administration (ORA) at King Abdullah University of Science and Technology (KAUST) under award number FCC/1/1976-44-01, FCC/1/1976-45-01, REI/1/5202-01-01, REI/1/5234-01-01, REI/1/4940-01-01, RGC/3/4816-01-01, and REI/1/0018-01-01. Xiaonan He was supported by the foundation of the National Natural Science Foundation of China (No. 62272327).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics committee of King Abdullah University of Science and Technology gave ethical approval for this workI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.Yes